Investors Research Corp
Position in CRL — Charles River Laboratories International, Inc.
CIK 1730630
ATLANTA, GA
Position in CRL
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,814
+$434 QoQ
Shares Held
8
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#521
of 564 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Investors Research Corp holds $995,556 across 8 Diagnostics & Research names. CRL ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,810 | $535,248 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
2,070 | $399,965 | |
| 3 | A |
Agilent Technologies, Inc.
|
382 | $50,741 | |
| 4 | WAT |
Waters Corp /De/
|
10 | $3,750 | |
| 5 | NTRA |
Natera, Inc.
|
9 | $2,443 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
This page
|
8 | $1,814 | |
| 7 | QGEN |
Qiagen N.V.
|
28 | $1,094 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
1 | $501 |
All Filings in CRL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,814 | 8 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,380 | 8 | Shares | Sole | 2026-04-03 | |
| No filing history on record for this holder in this stock. | ||||||